期刊文献+

基质金属蛋白酶-3在强直性脊柱炎中的作用和意义探讨 被引量:14

The significance of matrix metalloproteinase-3 response down-regulation in the treatment of ankylosing spondylitis by anti-TNFα monoclonal antibody remicade
下载PDF
导出
摘要 目的通过比较强直性脊柱炎(AS)病人抗肿瘤坏死因子(TNF)-α单克隆抗体药物(remicade)治疗前后的膝关节滑膜细胞的基因谱变化,找出缓解AS病情相关的主要基质金属蛋白酶(MMP)-3,并探讨MMP-3潜在调控的作用和在AS发病中的作用机制和意义。方法从AS病人在remicade治疗前和治疗3个月后的关节滑膜细胞的基因表达谱(用含1176基因的cDNA微阵列检测)结果中筛选的靶基因即差异表达最显著的MMP-3为特异性刺激因子,用反转录-聚合酶链反应(RT-PCR)方法检测它诱导健康志愿者外周血单个核细胞(PBMC)的炎症相关基因TNF-α、c-jun和c-fos的表达。结果比较AS病人治疗前后的关节滑膜细胞基因差异表达的结果,MMP-3治疗后下调最显著(P=0.0147)。与MMP-3聚类在一起的基因有111个,和MMP-3相关性最强的基因是金属蛋白酶抑制剂前体(TIMP)-1;MMP-3能显著诱导PBMC的TNF-α、c-jun和c-fos的表达。结论在remicade治疗AS过程中,下调MMP-3是最重要的环节之一;通过检测MMP-3在关节滑膜细胞组织中的表达水平可作为AS诊断和病情进展监控的参考指标;MMP-3下调,可能使TNF-TNFR2-JNK-AP-1信息通道的激活状态减弱,从而减少致炎因子的释放,调整异常的基质降解和血管形成等病理因素,缓解AS炎症、减少软骨和骨质破坏的作用。 Objective To compare the gene expression profiles of knee synovial tissues of ankylosing spondylitis (AS) patients before and after the anti-TNF-?琢 monoclonal antibody drug remicade treatment.And to screen out the genes MMP-3 which were the potential gene target related with the pathogenesis of AS,evaluate its possible action and significance.Methods Knee synovial tissues obtained from patients with active AS before and after 3 months of treatment with remicade microarray experiments was carried out with 1176 target gene filters using total RNA of those with AS.After stimulated by microarray positive matrix metalloproteinases (MMP)-3,measurement of the expression of TNF-α,c-jun and c-fos in PBMC which obtained from healthy volunteers was performed with semi-quantitative PT-PCR.Results After comparing the gene differential expression of active AS patients before and after treatment,MMP-3 was the most promising microarray candidate,which became significantly down-regulated after remicade treatmext(P=0.0147).According to the results of clusting of microarray genes expression,there were 111 genes clusted in the same group with MMP-3.Metalloproteinase inhibitor-1 precursor (TIMP-1) had the strongest correlation with MMP-3;TNF-α,c-jun and c-fos were indeed strongly expressed in PBMC of healthy volunteers after stimulated by MMP-3.Conclusion During treatment with remicade,the most remarkable response is down-regulation of MMP-3 in the knee synovial tissues of patients with AS.Measurement of the expression level of MMP-3 is a valuable index for diagnosis and following up of the disease status.These data confirm the effect of anti-TNF-?琢 on the immune system,that the active state of TNF-TNFR2-JNK-AP-1 signal pathway has been weakened by down-regulation of MMP-3 after remicade treatment,thus decreasing the release of proinflammatory cytokines.This would alleviate cartilage and bone destruction,and induce proliferation and development of pannus.
出处 《中国药物与临床》 CAS 2004年第4期270-276,共7页 Chinese Remedies & Clinics
基金 国家自然科学基金委国家杰出青年科研基金资助项(30325019 30025041) 国家教委博士点基金资助项目(2002558082) 广州市科委基金资助项目(2002E3-E4021)
  • 相关文献

参考文献28

  • 1[1]Beutler BA.The role of tumor necrosis factor in health anddisease.J Rheumatol,1999,57(1):16-21. 被引量:1
  • 2[2]Braun J,Bollow M,Neure L,et al.Use of immunohistologic and insitu hybridization techniques in the examination of sacroiliac jointbiopsy specimens from patients with ankylosing spondylitis.Arthritis Rheum,1995,38(4): 499-505. 被引量:1
  • 3[3]Brandt J,Haibel H,Sieper J,et al.Infliximab treatment of severeankylosing spondylitis:one-year follow-up.Arthritis Rheum,2002,44(12):2936-2945. 被引量:1
  • 4[4]Brandt J,Haibel H,Cornely D,et al.Successful treatment of activeankylosing spondylitis with the anti-tumor necrosis factor-αmonoclonal antibody infliximab.Arthritis Rheu,2000,43(6):1346-1352. 被引量:1
  • 5[5]Braun J,Brandt J,Listin J,et al.Treatment of active ankylosingspondylitis with infliximab: a randomized controlled multicentertrial.Lancet,2002,359(9313): 1187-1193. 被引量:1
  • 6古洁若,黄烽,颜光美,李天旺,吴玉琼,余得恩.Remicade调节强直性脊柱炎患者滑膜细胞基因表达谱的初步研究[J].中华风湿病学杂志,2003,7(10):591-595. 被引量:12
  • 7古洁若,黄烽,余得恩.cDNA芯片技术在强直性脊柱炎研究中的初步应用[J].中华医学杂志,2001,81(17):1030-1034. 被引量:23
  • 8[8]Gu J,Rihl M,Marker-Hermann E,et al.Clues to pathogenesis ofSpondyloarthropathy derived from synovial-fluid-mononuclearcell gene expression profiles.J Rheumatol,2002,29(10):2159-64. 被引量:1
  • 9[9]Seta N,Granfors K,Sahly H,et al.Expression of host defensescavenger receptors in spondyloarthropathy.Arthritis Rheum,2001,44(4): 931-939 被引量:1
  • 10[10]Elsen M,Spellman P,Brown P,et al.Cluster analysis and display ofgenome-wide expression patterns.Proc Natl Acad Sci USA,1998,95:14863-14868. 被引量:1

二级参考文献15

  • 1McGonagle D, Benjamin M, Marzo-Ortega H, et al. Advances in the understanding of entheseal inflammation, Curt Rheumatol Rep, 2002,4: 500-506. 被引量:1
  • 2Beutler BA. The role of ttanor necrosis factor in health and diseaes. J Rheumatol, 1999,27:16-21. 被引量:1
  • 3Brandt J,Haibel H,Cornely D,et al. Successful treatment of active ankylosing spondylitis with the anti-ttanor necrosis factor a monclonal antibody "infliximab. Arthritis Rheum, 2000,43 : 1346-1352. 被引量:1
  • 4Braun J, Brandt J, Listin J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicenter trial. Lancet, 2002,359:1187-1193. 被引量:1
  • 5Van den Bosch F, Kruithof D, Baeten F, et al. Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study see (comments). Ann Rheum Dis, 2000, 59:428. 被引量:1
  • 6Panayi GS, Corrigall VM, Pitzalis C. Pathogenesis of rheumatoid arthritis:the role of T cells and other beasts. Rheum Dis Clin North Am, 2001,27:317-334. 被引量:1
  • 7Hammer RE,Maika SD, Richardson JA, et al. Spontaneous inflammatory.disease in transgenlc rats expressing HLA-B27 and human beta 2re:an animal model of HLA-B27 associated human disorders. Cell, 1990,63:1099. 被引量:1
  • 8Zou J, Rudwaleit M, Brandt J, et al. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis durniog treatment with infliximab. Arthritis Rheum,2003,48: 780-790. 被引量:1
  • 9Baeten D,Van Damme N, Van den Bosch F,et al. Impired Thl cytokine production in spondyloarthropathy is restored by anti-TNF-α. Ann Rheum Dis,2001,60:750-755. 被引量:1
  • 10Klimiuk PA, Sierakowski S, Latosiewicz R, et al. Soluble adhesion molecules (ICAM-1, VCAM-1 and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis,2002,61:804-809. 被引量:1

共引文献31

同被引文献118

引证文献14

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部